{"id":"https://genegraph.clinicalgenome.org/r/5e101759-5308-4609-9e00-fef186437342v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between *GTPBP3* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of May 23, 2024. The *GTPBP3* gene encodes the GTP-binding protein 3 important for modification of the uridine at the wobble base of five mitochondrial transfer RNAs (Gln, Glu, Lys, LeuUUR, Trp), which is critical for mitochondrial translation.\n\n*GTPBP3* was first reported in relation to autosomal recessive primary mitochondrial disease in 2014 (PMID: 25434004). While various names have been given to the constellation of features seen in those with *GTPBP3*-related disorders, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the GTPBP3 phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Of note, *GTPBP3* was first curated by this Expert Panel for its association with Leigh syndrome spectrum (LSS) on January 13, 2020 (SOP v7), with a final classification of Moderate. This current curation for the association with primary mitochondrial disease includes the three cases included in the LSS curation.\n\nEvidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included 16 variants (10 missense, three frameshift, one in-frame deletion, one termination, and one splice site variant) in 12 probands from two publications (PMIDs: 25434004, 34276756). Age of onset ranges from infancy to adolescence. The outcomes are variable as some individuals live into the teens and at least one reported individual lived to the third decade (PMID: 37029485).  Clinical features include hypertrophic cardiomyopathy, arrhythmia, lactic acidosis, LSS, developmental delay, seizures, feeding difficulty, and intrauterine growth restriction. Variable respiratory chain enzyme deficiencies have been reported in skeletal muscle.\n\nThe mechanism of disease is loss of function. This gene-disease association is also supported by its known biochemical function of GTPBP3 in modification of mitochondrial tRNAs, functional alteration in patient and non-patient cells, rescue in patient cells, and zebrafish and worm models (PMIDs: 25434004, 29390138, 30916346, 28732077). \n\nIn summary, there is definitive evidence to support the relationship between *GTPBP3* and primary mitochondrial disease. This relationship has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on May 23, 2024 (SOP Version 10).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5e101759-5308-4609-9e00-fef186437342","GCISnapshot":"https://genegraph.clinicalgenome.org/r/393ee652-756b-4b54-9e0a-916bbae9d9eb","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/393ee652-756b-4b54-9e0a-916bbae9d9eb_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2025-02-05T23:10:53.395Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/393ee652-756b-4b54-9e0a-916bbae9d9eb_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2024-05-23T04:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/393ee652-756b-4b54-9e0a-916bbae9d9eb_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/393ee652-756b-4b54-9e0a-916bbae9d9eb_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67020512-5fd1-44fe-8cc2-cb164eebe958","type":"EvidenceLine","dc:description":"gtpbp3 knockout zebrafish generated by CRISPR/Cas9; showed impaired mitochondrial translation, increased proteostasis stress and altered activities of respiratory chain complexes; resulted in alterations in the embryonic heart development and reduced fractional shortening of ventricles in mutant zebrafish, gtpbp3 knock-out zebrafish exhibited hypertrophy of cardiomyocytes and myocardial fiber disarray in ventricles.\n","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a6ef4761-f078-42b1-8234-0cba219d65bf","type":"Finding","dc:description":"gtpbp3 knockout zebrafish generated by CRISPR/Cas9; showed impaired mitochondrial translation, increased proteostasis stress and altered activities of respiratory chain complexes; resulted in alterations in the embryonic heart development and reduced fractional shortening of ventricles in mutant zebrafish, gtpbp3 knock-out zebrafish exhibited hypertrophy of cardiomyocytes and myocardial fiber disarray in ventricles.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30916346","rdfs:label":"Chen - Zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/cebdb0b7-b2f8-4f01-bd2b-2be569e8ffc4","type":"EvidenceLine","dc:description":"mtcu-1 deletion showed slight decrease in steady state level of cI subunit, mild OXPHOS dysfunction (reduced maximal OCR), moderate increase in ROS (upregulation in genes involved in antioxidant response), reduced fertility\n","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1485143a-822f-439b-9b34-ef0790be6ccf","type":"Finding","dc:description":"mtcu-1 deletion showed slight decrease in steady state level of cI subunit, mild OXPHOS dysfunction (reduced maximal OCR), moderate increase in ROS (upregulation in genes involved in antioxidant response), reduced fertility\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28732077","rdfs:label":"Navarro-Gonzales - C. Elegans","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/075a2489-deb6-40e3-a242-994c37ca914c","type":"EvidenceLine","dc:description":"Authors transduced patient cell line (#66143) with wild-type copy of GTPBP3 cDNA by using a lentiviral vector (fibroblasts from #66654 - subject with only one affected allele- being included as a control, C6). \nTransduction had no noticeable effect on the control cell line (C6-T), transduced fibroblasts from #66143 (#66143-T) displayed a significant improvement of OCR in galactose-containing medium\n","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35f61cac-9ac0-4c10-ba3c-bbda67ebb046","type":"Finding","dc:description":"Authors transduced patient cell line (#66143) with wild-type copy of GTPBP3 cDNA by using a lentiviral vector (fibroblasts from #66654 - subject with only one affected allele- being included as a control, C6). \nTransduction had no noticeable effect on the control cell line (C6-T), transduced fibroblasts from #66143 (#66143-T) displayed a significant improvement of OCR in galactose-containing medium\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","rdfs:label":"Kopajtich - Rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/393ee652-756b-4b54-9e0a-916bbae9d9eb_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2cf9686-59ad-4e7c-b63a-78b83702e084","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0aa4e2c-82cf-4027-b8dc-35f86e98c337","type":"FunctionalAlteration","dc:description":"Mitochondrial translation products were decreased, there were strongly reduced amounts of steady state levels of nuclear-encoded CIV subunits, there was decreased in OCR.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","rdfs:label":"Kopajtich - Functional alteration in patient cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/620c2bf1-3fc8-4ad5-bcd7-a8f5e68db2eb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d695dc7-8d60-4900-84a2-d73d64dd79b2","type":"FunctionalAlteration","dc:description":"GTPBP3 KO in HEK293T cells; severely reduced oxygen consumption rate, reduced complex I and IV activity but increased complex II activity, reduced levels of complex I proteins (ND2 and NDUFB8). Pulse labeling of mt protein synthesis showed a reduced rate.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29390138","rdfs:label":"Asano - Functional alteration in non-patient cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/52eec7c0-21a9-43af-ba61-35018fd57e70","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2cfd0fa8-93dd-40eb-bf8a-fb4f5f931c1e","type":"FunctionalAlteration","dc:description":"HeLa cells, downregulated expression (RNAi) of GTPBP3, resulted in a general mitochondrial translation defect, similarly to the reduction observed in subject fibroblasts\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","rdfs:label":"Kopajtich - Functional alteration in nonpatient cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/393ee652-756b-4b54-9e0a-916bbae9d9eb_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c36e9ad-200d-411b-ad9c-8ce9d7a4c14e","type":"EvidenceLine","dc:description":"Disorders of mitochondrial gene expression.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f9a0eef-9981-4ae9-95a2-7fb2cfc41a9c","type":"Finding","dc:description":"Disorders of mitochondrial gene expression\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","rdfs:label":"Disorders of mitochondrial gene expression","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/393ee652-756b-4b54-9e0a-916bbae9d9eb_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d6af94d-9ee3-48e9-94b9-76fae5a586d3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94b91234-d4d5-4fb5-a3d3-a7e68772f469","type":"EvidenceLine","dc:description":"This variant is predicted to cause the loss of a splice acceptor site. Analysis of cDNA from fibroblasts revealed a shorter transcript, and sequencing found that in more than 95% of transcripts, the downstream acceptor of exon 7 was used for splicing, resulting in the skipping of exon 6 including the conserved G1-box guanine nucleotide-binding signature motif.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94b91234-d4d5-4fb5-a3d3-a7e68772f469_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant is predicted to cause the loss of a splice acceptor site. Analysis of cDNA from fibroblasts revealed a shorter transcript, and sequencing found that in more than 95% of transcripts, the downstream acceptor of exon 7 was used for splicing, resulting in the skipping of exon 6 including the conserved G1-box guanine nucleotide-binding signature motif.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/94b91234-d4d5-4fb5-a3d3-a7e68772f469_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","allele":{"id":"https://genegraph.clinicalgenome.org/r/e43f6808-fc8c-4d8d-8a57-6d96486c3381","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001195422.1(GTPBP3):c.731-2del (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915940571"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/6d6af94d-9ee3-48e9-94b9-76fae5a586d3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","rdfs:label":"Kopajtich - 76671","allele":{"id":"https://genegraph.clinicalgenome.org/r/e43f6808-fc8c-4d8d-8a57-6d96486c3381"},"phenotypeFreeText":"This is a LSS case. This is a boy born to nonconsanguineous parents. At birth, he had hypotonia, difficulty with suck and rapidly developed FTT. By 7m, he achieved head control and had normal cognitive skills. At 9m, he had acute aspiration pneumonia that required intubation. Cardiac exam showed HCM and WPW. He died after 15 days of hospitalization with clinical signs of heart failure at age 10m.\n","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/94b91234-d4d5-4fb5-a3d3-a7e68772f469_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/93e01f0f-ad03-4bfe-aab9-68cba71d6ae5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/264d5bcd-c701-4b18-b496-8c65e9f0013c","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/264d5bcd-c701-4b18-b496-8c65e9f0013c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","allele":{"id":"https://genegraph.clinicalgenome.org/r/889d8969-bab2-4403-994c-1a058e8c092a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032620.4(GTPBP3):c.770C>A (p.Pro257His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA404737052"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/93e01f0f-ad03-4bfe-aab9-68cba71d6ae5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","rdfs:label":"Kopajtich - 75168","allele":{"id":"https://genegraph.clinicalgenome.org/r/889d8969-bab2-4403-994c-1a058e8c092a"},"phenotypeFreeText":"This is a girl born to consanguineous (first cousins) parents. At 2y, she had developmental delay and was able to walk but not speak. At 3y, during febrile illness, she had acute metabolic failure and elevated blood lactate. She recovered but had epileptic seizures and more severe ID. She is currently delayed but doing well in special school.\n","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/264d5bcd-c701-4b18-b496-8c65e9f0013c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/1efa82f9-747b-4026-9fc5-be5cd749c553_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d5be0598-0068-44cb-90ab-81caccfabbbb","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d5be0598-0068-44cb-90ab-81caccfabbbb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34276756","allele":{"id":"https://genegraph.clinicalgenome.org/r/54568b32-01d9-4a88-9ce8-14ef0a5eddeb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032620.4(GTPBP3):c.689A>C (p.Gln230Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9293463"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2fdff1ad-5def-437d-9712-d679142d5ca1","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2fdff1ad-5def-437d-9712-d679142d5ca1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34276756","allele":{"id":"https://genegraph.clinicalgenome.org/r/440b4719-b5ca-408e-9330-4daf8383edb9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032620.4(GTPBP3):c.424G>A (p.Glu142Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA404732796"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1efa82f9-747b-4026-9fc5-be5cd749c553","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34276756","rdfs:label":"Yan - Patient 3","allele":[{"id":"https://genegraph.clinicalgenome.org/r/54568b32-01d9-4a88-9ce8-14ef0a5eddeb"},{"id":"https://genegraph.clinicalgenome.org/r/440b4719-b5ca-408e-9330-4daf8383edb9"}],"phenotypeFreeText":"This is a Chinese girl, admitted at 1y9m after three episodes of sudden convulsions. She also had mild developmental delay and intellectual disability, fatigability, and hypertrophic cardiomyopathy. At 3y9m, she could walk and run but easily fell down, could understand most of the othersâ€™ expressions and speak a few words but was unable to construct a complete sentence; found to have LV hypertrophy.","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d5be0598-0068-44cb-90ab-81caccfabbbb_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/2fdff1ad-5def-437d-9712-d679142d5ca1_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/0c3c0659-7202-45ce-8212-e8cc868b53a6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bae3e64-e38b-49e7-9e49-9fe401d0e259","type":"EvidenceLine","dc:description":"Muscle showed decreased CI (12%) and CIV (17%).","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bae3e64-e38b-49e7-9e49-9fe401d0e259_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Muscle showed decreased CI (12%) and CIV (17%).\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2bae3e64-e38b-49e7-9e49-9fe401d0e259_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","allele":{"id":"https://genegraph.clinicalgenome.org/r/440b4719-b5ca-408e-9330-4daf8383edb9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0c3c0659-7202-45ce-8212-e8cc868b53a6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","rdfs:label":"Kopajtich - 81471","allele":{"id":"https://genegraph.clinicalgenome.org/r/440b4719-b5ca-408e-9330-4daf8383edb9"},"phenotypeFreeText":"This is a boy born to nonconsanguineous Romanian parents at 34 weeks gestation.  On DOL25, he was readmitted to hospital for weight loss. He was hypothermic and jaundiced and initial blood analysis showed profound metabolic acidosis. He had little spontaneous movement on exam and was hypotonic. ECG was abnormal and echocardiography showed concentric left ventricular hypertrophy. \nDeveloped recurrent apnea and died at 5w.\n","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2bae3e64-e38b-49e7-9e49-9fe401d0e259_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/baf54f99-6886-4637-82cd-2c296f97f251_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9d196b19-2423-40e7-adcc-60babf0f2311","type":"EvidenceLine","dc:description":"Muscle showed decreased CI (15%) and CIV (24%). This is predicted to escape NMD.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9d196b19-2423-40e7-adcc-60babf0f2311_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Muscle showed decreased CI (15%) and CIV (24%). This is predicted to escape NMD.\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9d196b19-2423-40e7-adcc-60babf0f2311_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","allele":{"id":"https://genegraph.clinicalgenome.org/r/0de31563-2776-4e38-a2c3-c80fcf7239ca","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032620.4(GTPBP3):c.1291dup (p.Arg431ProfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358281"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.25},{"id":"https://genegraph.clinicalgenome.org/r/78514761-34bc-4fd5-a87a-36751f3c0d50","type":"EvidenceLine","dc:description":"Muscle showed decreased CI (15%) and CIV (24%). ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78514761-34bc-4fd5-a87a-36751f3c0d50_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Muscle showed decreased CI (15%) and CIV (24%). ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/78514761-34bc-4fd5-a87a-36751f3c0d50_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","allele":{"id":"https://genegraph.clinicalgenome.org/r/f62507a1-2fb5-4c3b-8b90-acaca7882169","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032620.4(GTPBP3):c.1375G>A (p.Glu459Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10575671"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/baf54f99-6886-4637-82cd-2c296f97f251","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","rdfs:label":"Kopajtich - 49665","allele":[{"id":"https://genegraph.clinicalgenome.org/r/0de31563-2776-4e38-a2c3-c80fcf7239ca"},{"id":"https://genegraph.clinicalgenome.org/r/f62507a1-2fb5-4c3b-8b90-acaca7882169"}],"phenotypeFreeText":"This is a boy born to consanguineous parents from the UAE. His history is as follows:\n10y: Mild intellectual disability, fatigability, mild hypertrophic cardiomyopathy, and visual impairment; slight dyspnea when climbing stairs; pale optic discs\nNormal EEG, hearing, VEPs\nEKG showed left ventricular hypertrophy confirmed by echo\nSimilarly affected sib\n","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/9d196b19-2423-40e7-adcc-60babf0f2311_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/78514761-34bc-4fd5-a87a-36751f3c0d50_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2e48b428-279d-43e0-818d-72d50c8755e5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d6abff5-d96a-4e8c-8342-bb3197872c6e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d6abff5-d96a-4e8c-8342-bb3197872c6e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34276756","allele":{"id":"https://genegraph.clinicalgenome.org/r/c16b60f4-cce2-443d-bccc-fe0793c0ac78","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032620.4(GTPBP3):c.413C>T (p.Ala138Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9293353"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6aa75ace-de2f-453c-b6e9-c5f772be048e","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6aa75ace-de2f-453c-b6e9-c5f772be048e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34276756","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fab1f2e-e761-4ab8-bcf8-900e522478ab","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032620.4(GTPBP3):c.509_510del (p.Glu170GlyfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA632134129"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2e48b428-279d-43e0-818d-72d50c8755e5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34276756","rdfs:label":"Yan - Patient 1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/1fab1f2e-e761-4ab8-bcf8-900e522478ab"},{"id":"https://genegraph.clinicalgenome.org/r/c16b60f4-cce2-443d-bccc-fe0793c0ac78"}],"phenotypeFreeText":"This is a Chinese boy with poor feeding after birth. At 17h, he experienced sudden dyspnea, cyanosis, mild stridor, and difficulty in suction. Chest x-ray showed significant cardiomegaly. He died of congestive heart failure at 4d.\n","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/6aa75ace-de2f-453c-b6e9-c5f772be048e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/3d6abff5-d96a-4e8c-8342-bb3197872c6e_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/1d8cf1e7-9fc8-4deb-b68b-a5df85c2c4c5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d07e4c77-6d6d-459a-881f-1afce018e846","type":"EvidenceLine","dc:description":"Muscle showed CI (14%) and CIV (45%) deficiency.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d07e4c77-6d6d-459a-881f-1afce018e846_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Muscle showed CI (14%) and CIV (45%) deficiency.\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d07e4c77-6d6d-459a-881f-1afce018e846_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","allele":{"id":"https://genegraph.clinicalgenome.org/r/a9dffaf1-f920-424d-b33a-467d215a6175","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001195422.1(GTPBP3):c.550G>C (p.Ala184Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA404733190"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/97c162e8-6725-4f65-9d3d-a7b1ce0da89f","type":"EvidenceLine","dc:description":"c.673G>A(p.Glu225Lys) in cis with c.964G>C(p.Ala322Pro).\nMuscle showed CI (14%) and CIV (45%) deficiency.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97c162e8-6725-4f65-9d3d-a7b1ce0da89f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"c.673G>A(p.Glu225Lys) in cis with c.964G>C(p.Ala322Pro).\nMuscle showed CI (14%) and CIV (45%) deficiency.\n\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/97c162e8-6725-4f65-9d3d-a7b1ce0da89f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","allele":{"id":"https://genegraph.clinicalgenome.org/r/7578263e-98ff-4da6-ac35-6033745d095a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032620.4(GTPBP3):c.964G>C (p.Ala322Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA185919"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/1d8cf1e7-9fc8-4deb-b68b-a5df85c2c4c5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","rdfs:label":"Kopajtich - 72425","allele":[{"id":"https://genegraph.clinicalgenome.org/r/7578263e-98ff-4da6-ac35-6033745d095a"},{"id":"https://genegraph.clinicalgenome.org/r/a9dffaf1-f920-424d-b33a-467d215a6175"}],"phenotypeFreeText":"This is a LSS case.  This is a girl born to nonconsanguineous parents. At 3m, she had feeding difficulties, FTT. At 7m. she developed recurrent cough and fever and was admitted to the emergency room with severe fatigue, pallor, and progressive malaise. Blood exams showed leukocytosis, and 2 days later her general condition worsened, showing cyanosis and hyporeactivity. Echocardiography showed severe dilated cardiomyopathy with an ejection fraction of 20% that was unresponsive to therapy. She died 10 days after admission from cardiac failure.\n","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/97c162e8-6725-4f65-9d3d-a7b1ce0da89f_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d07e4c77-6d6d-459a-881f-1afce018e846_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a7b47eb3-cb9c-4d24-8ae5-a98b5d4a0100_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc0143a0-4935-49c2-94df-488120b032dc","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc0143a0-4935-49c2-94df-488120b032dc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34276756","allele":{"id":"https://genegraph.clinicalgenome.org/r/f7d60676-679a-4a46-9089-759185fd3dda","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032620.4(GTPBP3):c.544G>T (p.Gly182Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA404734384"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/4b5081d9-0277-4ff8-a171-daf44e351e95","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b5081d9-0277-4ff8-a171-daf44e351e95_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34276756","allele":{"id":"https://genegraph.clinicalgenome.org/r/54568b32-01d9-4a88-9ce8-14ef0a5eddeb"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a7b47eb3-cb9c-4d24-8ae5-a98b5d4a0100","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34276756","rdfs:label":"Yan - Patient 2","allele":[{"id":"https://genegraph.clinicalgenome.org/r/54568b32-01d9-4a88-9ce8-14ef0a5eddeb"},{"id":"https://genegraph.clinicalgenome.org/r/f7d60676-679a-4a46-9089-759185fd3dda"}],"phenotypeFreeText":"This is a Chinese girl. At 1y, she had developmental delay, inflexibility of the lower extremities, and inability to stand walk alone, or speak. At 2.5y, she was admitted to hospital, could not walk, speak, run; exam showed hypotonia; little improvement over next several months.\n","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/4b5081d9-0277-4ff8-a171-daf44e351e95_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/fc0143a0-4935-49c2-94df-488120b032dc_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/70619843-87ea-44c3-97a9-3a2b34069438_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f0ce8c7-c4cd-45d7-a0be-09d65382376d","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f0ce8c7-c4cd-45d7-a0be-09d65382376d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","allele":{"id":"https://genegraph.clinicalgenome.org/r/3182d2bf-8503-4644-878c-ce2493adfe64","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032620.4(GTPBP3):c.32_33delinsGTG (p.Gln11ArgfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10575673"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/70619843-87ea-44c3-97a9-3a2b34069438","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","rdfs:label":"Kopajtich - 83904","allele":{"id":"https://genegraph.clinicalgenome.org/r/3182d2bf-8503-4644-878c-ce2493adfe64"},"phenotypeFreeText":"This is a girl born to consanguineous Turkish parents. Shortly after birth, she had WPW arrhythmia. At \n7m, she had cardiogenic shock and metabolic acidosis and heart US showed dilated cardiomyopathy and decreased contractility (ejection fraction 35%).  This progressed and died at 9m of cardiac insufficiency with arrhythmia. Her younger sister (#83905) was similarly affected and died at 6m due to cardiac insufficiency unresponsive to resuscitation procedures.\n","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4f0ce8c7-c4cd-45d7-a0be-09d65382376d_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/08cc3631-462d-43e3-91ef-024c8910aff2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3f8f7f4-cc95-428f-8d75-8c8ec6458c81","type":"EvidenceLine","dc:description":"Muscle (immediately after death) showed decreased CI (31%) and CIV (15%).","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3f8f7f4-cc95-428f-8d75-8c8ec6458c81_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Muscle (immediately after death) showed decreased CI (31%) and CIV (15%).\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a3f8f7f4-cc95-428f-8d75-8c8ec6458c81_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","allele":{"id":"https://genegraph.clinicalgenome.org/r/16e1f39e-ba83-4870-a4ae-052fc6b8f01d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032620.4(GTPBP3):c.1009G>C (p.Asp337His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10575672"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/08cc3631-462d-43e3-91ef-024c8910aff2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","rdfs:label":"Kopajtich - 75191","allele":{"id":"https://genegraph.clinicalgenome.org/r/16e1f39e-ba83-4870-a4ae-052fc6b8f01d"},"phenotypeFreeText":"This is a girl born to nonconsanguineous parents. Hours after birth she had mild stridor and dyspnea which rapidly worsened. She had poor feeding and became less responsive, had a Kussmaul breathing pattern; was severely hypotonic, had little spontaneous movement, and progressively developed respiratory insufficiency and bradycardia. She died of asystolia at day 1.\n","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a3f8f7f4-cc95-428f-8d75-8c8ec6458c81_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a2f3a525-5a2a-483c-9b6e-863fded42703_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e45eb190-ac94-43f4-bb61-fd154093d7fb","type":"EvidenceLine","dc:description":"Muscle showed decreased CI (7%) and CIV (28%).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e45eb190-ac94-43f4-bb61-fd154093d7fb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Muscle showed decreased CI (7%) and CIV (28%).\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e45eb190-ac94-43f4-bb61-fd154093d7fb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","allele":{"id":"https://genegraph.clinicalgenome.org/r/7eabc62c-d305-4fff-97e0-6ab7ca06b2c3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032620.4(GTPBP3):c.476A>T (p.Glu159Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA185917"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/db66ba6d-1ce2-4890-800c-b960ad0bd186","type":"EvidenceLine","dc:description":"Muscle showed decreased CI (7%) and CIV (28%).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db66ba6d-1ce2-4890-800c-b960ad0bd186_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Muscle showed decreased CI (7%) and CIV (28%).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/db66ba6d-1ce2-4890-800c-b960ad0bd186_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","allele":{"id":"https://genegraph.clinicalgenome.org/r/7578263e-98ff-4da6-ac35-6033745d095a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/a2f3a525-5a2a-483c-9b6e-863fded42703","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","rdfs:label":"Kopajtich - 66143","allele":[{"id":"https://genegraph.clinicalgenome.org/r/7578263e-98ff-4da6-ac35-6033745d095a"},{"id":"https://genegraph.clinicalgenome.org/r/7eabc62c-d305-4fff-97e0-6ab7ca06b2c3"}],"phenotypeFreeText":"This is a boy (from Israel, parents unrelated) with the following history:\n2y: sudden respiratory failure; heart US showed HCM and congestive heart failure, improved with medication\n3y: Normal psychomotor development, active like peers; stopped some medications and cardiac concerns were stable\n","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/db66ba6d-1ce2-4890-800c-b960ad0bd186_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e45eb190-ac94-43f4-bb61-fd154093d7fb_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ebbac560-c49a-4ec8-8070-b95eb3af798e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42586bc3-0df1-450c-8c8d-60a5b7341972","type":"EvidenceLine","dc:description":"This varaint is located at the very N terminus of the protein, causes a loss of a positively charged residue, which is predicted to interfere with mitochondrial targeting and the patient had respiratory chain enzyme deficiency.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42586bc3-0df1-450c-8c8d-60a5b7341972_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","allele":{"id":"https://genegraph.clinicalgenome.org/r/ef0e9edd-e89b-4df5-a4d5-1a3e59a5007a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001195422.1(GTPBP3):c.120-389G>T (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA404730351"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/64dde1cb-8b3b-4b1b-a713-20e1e46b55d9","type":"EvidenceLine","dc:description":"This variant is a deletion and the patient had respiratory chain enzyme deficiency.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/64dde1cb-8b3b-4b1b-a713-20e1e46b55d9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","allele":{"id":"https://genegraph.clinicalgenome.org/r/35e24571-f35c-4cea-9ade-00bc8f477ab5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001195422.1(GTPBP3):c.1000_1023del (p.Gly334_Val341del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9293572"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.25},{"id":"https://genegraph.clinicalgenome.org/r/ebbac560-c49a-4ec8-8070-b95eb3af798e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25434004","rdfs:label":"Kopajtich - 82790","allele":[{"id":"https://genegraph.clinicalgenome.org/r/ef0e9edd-e89b-4df5-a4d5-1a3e59a5007a"},{"id":"https://genegraph.clinicalgenome.org/r/35e24571-f35c-4cea-9ade-00bc8f477ab5"}],"phenotypeFreeText":"This is a LSS case. This is a girl born to nonconsanguineous Japanese parents. At 1y, she developed frequent epileptic seizures. At 15m, she had severe developmental delay and hypotonia. A 2y, she had severe global delay. Echo and EKG were normal. \n\nBrain MRI showed bilateral hyperintensities in the putamen and weakly also in the anterior thalamus. Brain MRS showed lactate peak. She had elevated blood lactate (5.72-6.49 mmol/L); normal amino acids, organic acids, acylcarnitine profile. Muscle showed decreased CI (36%) and CIV (21%).\n\n\n","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/42586bc3-0df1-450c-8c8d-60a5b7341972_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/64dde1cb-8b3b-4b1b-a713-20e1e46b55d9_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.75}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":9933,"specifiedBy":"GeneValidityCriteria10","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/lzuQGDvSKX4","type":"GeneValidityProposition","disease":"obo:MONDO_0044970","gene":"hgnc:14880","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_393ee652-756b-4b54-9e0a-916bbae9d9eb-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}